These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7831370)

  • 1. Endotoxin and the release of tumor necrosis factor receptors.
    Jansen J; van der Poll T; van Deventer SJ
    Prog Clin Biol Res; 1994; 388():383-97. PubMed ID: 7831370
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands.
    Pfeffer K
    Eur Cytokine Netw; 2000 Sep; 11(3):514. PubMed ID: 11203200
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of cachectin/TNF and other cytokines in sepsis.
    Zentella A; Manogue K; Cerami A
    Prog Clin Biol Res; 1991; 367():9-24. PubMed ID: 1924435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor necrosis factor ligand and receptor families.
    Bazzoni F; Beutler B
    N Engl J Med; 1996 Jun; 334(26):1717-25. PubMed ID: 8637518
    [No Abstract]   [Full Text] [Related]  

  • 5. Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitis.
    Heumann D; Le Roy D; Zanetti G; Eugster HP; Ryffel B; Hahne M; Tschopp J; Glauser MP
    J Inflamm; 1995-1996; 47(4):173-9. PubMed ID: 9144074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of tumor necrosis factor alpha and its soluble receptor p55 in clinical septic syndrome.
    Modzelewski B
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):213-9. PubMed ID: 9597089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphotoxin and tumor necrosis factor: qualitative and quantitative differences in their receptors and signal transduction in various cell types.
    Aggarwal BB
    Prog Clin Biol Res; 1990; 349():375-84. PubMed ID: 2169060
    [No Abstract]   [Full Text] [Related]  

  • 8. Adenovirus-induced liver pathology is mediated through TNF receptors I and II but is independent of TNF or lymphotoxin.
    Hayder H; Blanden RV; Körner H; Riminton DS; Sedgwick JD; Müllbacher A
    J Immunol; 1999 Aug; 163(3):1516-20. PubMed ID: 10415054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cachectin/TNF mediates the pathophysiological effects of bacterial endotoxin/lipopolysaccharide (LPS).
    Tracey KJ; Lowry SF; Cerami A
    Prog Clin Biol Res; 1988; 272():77-88. PubMed ID: 3293084
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of tumor necrosis factor in systemic inflammatory responses in primate endotoxemia.
    van der Poll T; Levi M; ten Cate H; van Deventer SJ
    Prog Clin Biol Res; 1994; 388():425-33. PubMed ID: 7831375
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor necrosis factor signaling mechanisms.
    Goeddel DV
    Harvey Lect; 1996-1997; 92():41-54. PubMed ID: 15372742
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M; Medvedev AE; Sundan A; Espevik T
    Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute inflammation and microthrombosis induced by endotoxin, interleukin-1, and tumor necrosis factor and their implication in gram-negative infection.
    Cybulsky MI; Chan MK; Movat HZ
    Lab Invest; 1988 Apr; 58(4):365-78. PubMed ID: 3282123
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor necrosis factor and lymphotoxin ligand-receptor system in lymphoproliferative disorders.
    Warzocha K; Salles G; Coiffier B
    Acta Haematol Pol; 1995; 26(4):323-32. PubMed ID: 8571733
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting.
    Matsumoto M
    J Med Invest; 1999 Aug; 46(3-4):141-50. PubMed ID: 10687308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute renal failure and multiorgan failure.
    Wardle EN
    Nephrol Dial Transplant; 1994; 9 Suppl 4():104-7. PubMed ID: 7800240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ligands and receptors of the lymphotoxin system.
    Ware CF; VanArsdale TL; Crowe PD; Browning JL
    Curr Top Microbiol Immunol; 1995; 198():175-218. PubMed ID: 7774281
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis.
    Morrison DC; Bucklin SE
    Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.
    Spahn TW; Eugster HP; Fontana A; Domschke W; Kucharzik T
    Infect Immun; 2005 Nov; 73(11):7077-88. PubMed ID: 16239501
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.